Earliest prevention of endemic goiter by iodine supplementation during pregnancy
Liesenkötter KP, Göpel W, Bogner U, Stach B, Grüters A. Earliest prevention of endemic goiter by iodine supplementation during pregnancy. Eur J Endocrinol 1996;134:443–8. ISSN 0804–4643 During pregnancy complex changes of maternal thyroid function occur and they are influenced by the maternal iodine...
Gespeichert in:
| Veröffentlicht in: | European journal of endocrinology 1996-04, Vol.134 (4), p.443-448 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 448 |
|---|---|
| container_issue | 4 |
| container_start_page | 443 |
| container_title | European journal of endocrinology |
| container_volume | 134 |
| creator | LIESENKÖTTER, K. P GÖPEL, W BOGNER, U STACH, B GRÜTERS, A |
| description | Liesenkötter KP, Göpel W, Bogner U, Stach B, Grüters A. Earliest prevention of endemic goiter by iodine supplementation during pregnancy. Eur J Endocrinol 1996;134:443–8. ISSN 0804–4643 During pregnancy complex changes of maternal thyroid function occur and they are influenced by the maternal iodine supply. It has been demonstrated that with decreasing iodine supply maternal goiter and hypothyroxinemia as well as fetal and neonatal hypothyroidism become more prevalent. Therefore iodine supplementation during pregnancy is now strongly recommended also in areas of moderate iodine deficiency. To monitor the success of iodine supplementation and its theoretical risk of increasing the frequency of thyroid autoantibodies, we have investigated the thyroid volume, thyroid function, urinary iodine excretion and antibodies to thyroid peroxidase at 10–12 weeks of gestation and postpartum in 38 mothers receiving 300 μg potassium iodide/day and in 70 mothers without iodine supplementation. In all of their newborns thyroid volume was determined by ultrasound. The thyrotropin (TSH) levels and antibodies to thyroid peroxidase (TPO-ab) in the neonates were measured in dried blood spots on filter paper from their newborn screening. Urinary iodine excretion was increased significantly after iodine supplementation in mothers (p < 0.001) and their newborns ( |
| doi_str_mv | 10.1530/eje.0.1340443 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78046233</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>78046233</sourcerecordid><originalsourceid>FETCH-LOGICAL-b390t-cbae5f534553661e4186f3afa16c6e2ae83aa1260538619f081adbee789ea263</originalsourceid><addsrcrecordid>eNqFkD1PwzAQhi0EKqUwMiJlQGwpduw4zoiq8iFVgqEDW3RxzpWrfGE3SP33uCRiZbpXusd3voeQW0aXLOX0Efe4DJELKgQ_I3MmsjyWin-ekzlVVMRCCn5JrrzfU8pCpjMyU1LQJE_n5GMNrrboD1Hv8Bvbg-3aqDMRthU2Vke7zh7QReUxsl1lW4z80Pc1NoGEX7YanG13p9e7Flp9vCYXBmqPN1NdkO3zert6jTfvL2-rp01c8pweYl0CpiblIk25lAwFU9JwMMCklpgAKg7AEklTriTLDVUMqhIxUzlCIvmCPIxje9d9DeH_RWO9xrqGFrvBF1m4XCacBzAeQe067x2aone2AXcsGC1OAosgsAhxFBj4u2nwUDZY_dGTsdC_n_rgNdTGhaOt_8M4VTKlWcD4iJW289qexBqr4Z_lPzOIipA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78046233</pqid></control><display><type>article</type><title>Earliest prevention of endemic goiter by iodine supplementation during pregnancy</title><source>Oxford University Press Journals All Titles (1996-Current)</source><source>MEDLINE</source><creator>LIESENKÖTTER, K. P ; GÖPEL, W ; BOGNER, U ; STACH, B ; GRÜTERS, A</creator><creatorcontrib>LIESENKÖTTER, K. P ; GÖPEL, W ; BOGNER, U ; STACH, B ; GRÜTERS, A</creatorcontrib><description>Liesenkötter KP, Göpel W, Bogner U, Stach B, Grüters A. Earliest prevention of endemic goiter by iodine supplementation during pregnancy. Eur J Endocrinol 1996;134:443–8. ISSN 0804–4643 During pregnancy complex changes of maternal thyroid function occur and they are influenced by the maternal iodine supply. It has been demonstrated that with decreasing iodine supply maternal goiter and hypothyroxinemia as well as fetal and neonatal hypothyroidism become more prevalent. Therefore iodine supplementation during pregnancy is now strongly recommended also in areas of moderate iodine deficiency. To monitor the success of iodine supplementation and its theoretical risk of increasing the frequency of thyroid autoantibodies, we have investigated the thyroid volume, thyroid function, urinary iodine excretion and antibodies to thyroid peroxidase at 10–12 weeks of gestation and postpartum in 38 mothers receiving 300 μg potassium iodide/day and in 70 mothers without iodine supplementation. In all of their newborns thyroid volume was determined by ultrasound. The thyrotropin (TSH) levels and antibodies to thyroid peroxidase (TPO-ab) in the neonates were measured in dried blood spots on filter paper from their newborn screening. Urinary iodine excretion was increased significantly after iodine supplementation in mothers (p < 0.001) and their newborns (<0.05). No hypo- or hyperthyroidism was observed in the mothers or newborns. Interestingly, no difference of maternal thyroid volumes was observed between the two groups after pregnancy, but the volumes of the thyroid glands in newborns of mothers who received iodine were significantly (p < 0.004) lower (0.7 ± 0.4 ml) than in the control group (1.5 ± 1.1 ml). There was no change in the frequency of TPO-ab in either group after pregnancy. In four mothers transplacental passage of these antibodies was documented by positive measurement in the blood sample of the newborn. This study documents that iodine supplementation during pregnancy in an area of moderate iodine deficiency results in a lower size of neonatal thyroid volume and that this supplementation was not accompanied by an increase in the frequency of TPO-ab. Klaus Peter Liesenkötter, Kinderklinik Kaiserin Auguste Victoria Haus (KAVH), Virchow-Klinikum der Medizinische Fakultät der Humboldt-Universität zu Berlin, Heubnerweg 6, 14059 Berlin, Germany</description><identifier>ISSN: 0804-4643</identifier><identifier>EISSN: 1479-683X</identifier><identifier>DOI: 10.1530/eje.0.1340443</identifier><identifier>PMID: 8640295</identifier><language>eng</language><publisher>Colchester: Portland Press</publisher><subject>Autoantibodies - blood ; Biological and medical sciences ; CLINICAL STUDIES ; Female ; Goiter, Endemic - prevention & control ; Hormones. Endocrine system ; Humans ; Iodide Peroxidase - immunology ; Maternal-Fetal Exchange ; Medical sciences ; Pharmacology. Drug treatments ; Potassium Iodide - administration & dosage ; Potassium Iodide - therapeutic use ; Pregnancy ; Thyrotropin - blood ; Thyroxine - blood ; Thyroxine-Binding Proteins - metabolism</subject><ispartof>European journal of endocrinology, 1996-04, Vol.134 (4), p.443-448</ispartof><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-b390t-cbae5f534553661e4186f3afa16c6e2ae83aa1260538619f081adbee789ea263</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3086507$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8640295$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>LIESENKÖTTER, K. P</creatorcontrib><creatorcontrib>GÖPEL, W</creatorcontrib><creatorcontrib>BOGNER, U</creatorcontrib><creatorcontrib>STACH, B</creatorcontrib><creatorcontrib>GRÜTERS, A</creatorcontrib><title>Earliest prevention of endemic goiter by iodine supplementation during pregnancy</title><title>European journal of endocrinology</title><addtitle>Eur J Endocrinol</addtitle><description>Liesenkötter KP, Göpel W, Bogner U, Stach B, Grüters A. Earliest prevention of endemic goiter by iodine supplementation during pregnancy. Eur J Endocrinol 1996;134:443–8. ISSN 0804–4643 During pregnancy complex changes of maternal thyroid function occur and they are influenced by the maternal iodine supply. It has been demonstrated that with decreasing iodine supply maternal goiter and hypothyroxinemia as well as fetal and neonatal hypothyroidism become more prevalent. Therefore iodine supplementation during pregnancy is now strongly recommended also in areas of moderate iodine deficiency. To monitor the success of iodine supplementation and its theoretical risk of increasing the frequency of thyroid autoantibodies, we have investigated the thyroid volume, thyroid function, urinary iodine excretion and antibodies to thyroid peroxidase at 10–12 weeks of gestation and postpartum in 38 mothers receiving 300 μg potassium iodide/day and in 70 mothers without iodine supplementation. In all of their newborns thyroid volume was determined by ultrasound. The thyrotropin (TSH) levels and antibodies to thyroid peroxidase (TPO-ab) in the neonates were measured in dried blood spots on filter paper from their newborn screening. Urinary iodine excretion was increased significantly after iodine supplementation in mothers (p < 0.001) and their newborns (<0.05). No hypo- or hyperthyroidism was observed in the mothers or newborns. Interestingly, no difference of maternal thyroid volumes was observed between the two groups after pregnancy, but the volumes of the thyroid glands in newborns of mothers who received iodine were significantly (p < 0.004) lower (0.7 ± 0.4 ml) than in the control group (1.5 ± 1.1 ml). There was no change in the frequency of TPO-ab in either group after pregnancy. In four mothers transplacental passage of these antibodies was documented by positive measurement in the blood sample of the newborn. This study documents that iodine supplementation during pregnancy in an area of moderate iodine deficiency results in a lower size of neonatal thyroid volume and that this supplementation was not accompanied by an increase in the frequency of TPO-ab. Klaus Peter Liesenkötter, Kinderklinik Kaiserin Auguste Victoria Haus (KAVH), Virchow-Klinikum der Medizinische Fakultät der Humboldt-Universität zu Berlin, Heubnerweg 6, 14059 Berlin, Germany</description><subject>Autoantibodies - blood</subject><subject>Biological and medical sciences</subject><subject>CLINICAL STUDIES</subject><subject>Female</subject><subject>Goiter, Endemic - prevention & control</subject><subject>Hormones. Endocrine system</subject><subject>Humans</subject><subject>Iodide Peroxidase - immunology</subject><subject>Maternal-Fetal Exchange</subject><subject>Medical sciences</subject><subject>Pharmacology. Drug treatments</subject><subject>Potassium Iodide - administration & dosage</subject><subject>Potassium Iodide - therapeutic use</subject><subject>Pregnancy</subject><subject>Thyrotropin - blood</subject><subject>Thyroxine - blood</subject><subject>Thyroxine-Binding Proteins - metabolism</subject><issn>0804-4643</issn><issn>1479-683X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkD1PwzAQhi0EKqUwMiJlQGwpduw4zoiq8iFVgqEDW3RxzpWrfGE3SP33uCRiZbpXusd3voeQW0aXLOX0Efe4DJELKgQ_I3MmsjyWin-ekzlVVMRCCn5JrrzfU8pCpjMyU1LQJE_n5GMNrrboD1Hv8Bvbg-3aqDMRthU2Vke7zh7QReUxsl1lW4z80Pc1NoGEX7YanG13p9e7Flp9vCYXBmqPN1NdkO3zert6jTfvL2-rp01c8pweYl0CpiblIk25lAwFU9JwMMCklpgAKg7AEklTriTLDVUMqhIxUzlCIvmCPIxje9d9DeH_RWO9xrqGFrvBF1m4XCacBzAeQe067x2aone2AXcsGC1OAosgsAhxFBj4u2nwUDZY_dGTsdC_n_rgNdTGhaOt_8M4VTKlWcD4iJW289qexBqr4Z_lPzOIipA</recordid><startdate>19960401</startdate><enddate>19960401</enddate><creator>LIESENKÖTTER, K. P</creator><creator>GÖPEL, W</creator><creator>BOGNER, U</creator><creator>STACH, B</creator><creator>GRÜTERS, A</creator><general>Portland Press</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960401</creationdate><title>Earliest prevention of endemic goiter by iodine supplementation during pregnancy</title><author>LIESENKÖTTER, K. P ; GÖPEL, W ; BOGNER, U ; STACH, B ; GRÜTERS, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-b390t-cbae5f534553661e4186f3afa16c6e2ae83aa1260538619f081adbee789ea263</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Autoantibodies - blood</topic><topic>Biological and medical sciences</topic><topic>CLINICAL STUDIES</topic><topic>Female</topic><topic>Goiter, Endemic - prevention & control</topic><topic>Hormones. Endocrine system</topic><topic>Humans</topic><topic>Iodide Peroxidase - immunology</topic><topic>Maternal-Fetal Exchange</topic><topic>Medical sciences</topic><topic>Pharmacology. Drug treatments</topic><topic>Potassium Iodide - administration & dosage</topic><topic>Potassium Iodide - therapeutic use</topic><topic>Pregnancy</topic><topic>Thyrotropin - blood</topic><topic>Thyroxine - blood</topic><topic>Thyroxine-Binding Proteins - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>LIESENKÖTTER, K. P</creatorcontrib><creatorcontrib>GÖPEL, W</creatorcontrib><creatorcontrib>BOGNER, U</creatorcontrib><creatorcontrib>STACH, B</creatorcontrib><creatorcontrib>GRÜTERS, A</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of endocrinology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>LIESENKÖTTER, K. P</au><au>GÖPEL, W</au><au>BOGNER, U</au><au>STACH, B</au><au>GRÜTERS, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Earliest prevention of endemic goiter by iodine supplementation during pregnancy</atitle><jtitle>European journal of endocrinology</jtitle><addtitle>Eur J Endocrinol</addtitle><date>1996-04-01</date><risdate>1996</risdate><volume>134</volume><issue>4</issue><spage>443</spage><epage>448</epage><pages>443-448</pages><issn>0804-4643</issn><eissn>1479-683X</eissn><abstract>Liesenkötter KP, Göpel W, Bogner U, Stach B, Grüters A. Earliest prevention of endemic goiter by iodine supplementation during pregnancy. Eur J Endocrinol 1996;134:443–8. ISSN 0804–4643 During pregnancy complex changes of maternal thyroid function occur and they are influenced by the maternal iodine supply. It has been demonstrated that with decreasing iodine supply maternal goiter and hypothyroxinemia as well as fetal and neonatal hypothyroidism become more prevalent. Therefore iodine supplementation during pregnancy is now strongly recommended also in areas of moderate iodine deficiency. To monitor the success of iodine supplementation and its theoretical risk of increasing the frequency of thyroid autoantibodies, we have investigated the thyroid volume, thyroid function, urinary iodine excretion and antibodies to thyroid peroxidase at 10–12 weeks of gestation and postpartum in 38 mothers receiving 300 μg potassium iodide/day and in 70 mothers without iodine supplementation. In all of their newborns thyroid volume was determined by ultrasound. The thyrotropin (TSH) levels and antibodies to thyroid peroxidase (TPO-ab) in the neonates were measured in dried blood spots on filter paper from their newborn screening. Urinary iodine excretion was increased significantly after iodine supplementation in mothers (p < 0.001) and their newborns (<0.05). No hypo- or hyperthyroidism was observed in the mothers or newborns. Interestingly, no difference of maternal thyroid volumes was observed between the two groups after pregnancy, but the volumes of the thyroid glands in newborns of mothers who received iodine were significantly (p < 0.004) lower (0.7 ± 0.4 ml) than in the control group (1.5 ± 1.1 ml). There was no change in the frequency of TPO-ab in either group after pregnancy. In four mothers transplacental passage of these antibodies was documented by positive measurement in the blood sample of the newborn. This study documents that iodine supplementation during pregnancy in an area of moderate iodine deficiency results in a lower size of neonatal thyroid volume and that this supplementation was not accompanied by an increase in the frequency of TPO-ab. Klaus Peter Liesenkötter, Kinderklinik Kaiserin Auguste Victoria Haus (KAVH), Virchow-Klinikum der Medizinische Fakultät der Humboldt-Universität zu Berlin, Heubnerweg 6, 14059 Berlin, Germany</abstract><cop>Colchester</cop><pub>Portland Press</pub><pmid>8640295</pmid><doi>10.1530/eje.0.1340443</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0804-4643 |
| ispartof | European journal of endocrinology, 1996-04, Vol.134 (4), p.443-448 |
| issn | 0804-4643 1479-683X |
| language | eng |
| recordid | cdi_proquest_miscellaneous_78046233 |
| source | Oxford University Press Journals All Titles (1996-Current); MEDLINE |
| subjects | Autoantibodies - blood Biological and medical sciences CLINICAL STUDIES Female Goiter, Endemic - prevention & control Hormones. Endocrine system Humans Iodide Peroxidase - immunology Maternal-Fetal Exchange Medical sciences Pharmacology. Drug treatments Potassium Iodide - administration & dosage Potassium Iodide - therapeutic use Pregnancy Thyrotropin - blood Thyroxine - blood Thyroxine-Binding Proteins - metabolism |
| title | Earliest prevention of endemic goiter by iodine supplementation during pregnancy |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-02T22%3A12%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Earliest%20prevention%20of%20endemic%20goiter%20by%20iodine%20supplementation%20during%20pregnancy&rft.jtitle=European%20journal%20of%20endocrinology&rft.au=LIESENK%C3%96TTER,%20K.%20P&rft.date=1996-04-01&rft.volume=134&rft.issue=4&rft.spage=443&rft.epage=448&rft.pages=443-448&rft.issn=0804-4643&rft.eissn=1479-683X&rft_id=info:doi/10.1530/eje.0.1340443&rft_dat=%3Cproquest_cross%3E78046233%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=78046233&rft_id=info:pmid/8640295&rfr_iscdi=true |